Salmonella is a global health threat, with pig production being one of the main sources of human salmonellosis. The current study investigated the antivirulence properties of geraniol for inhibiting the in vitro colonization of Salmonella. The minimum inhibitory (MIC) and bactericidal concentrations (MBC) of geraniol against Salmonella typhimurium followed by the sub-MIC of geraniol were determined. Results provided clear evidence that geraniol at 1/8 MIC can be used as an effective, non-toxic antivirulence compound to inhibit virulence factors (motility, adhesion, and invasiveness) affecting the colonization of S. typhimurium on IPEC-J2 cells. Additionally, the findings signified that microfluidics is an emerging technology suitable for the preparation of stable liposomes with a small size (<200 nm) and high encapsulation efficiency (EE) of up to 92.53%, which can act as effective carriers of geraniol into the pig gastrointestinal tract (GIT), targeting Salmonella, preventing colonization, and thus increasing the safety of the food supply chain.
Salmonella is a global health threat, with pig production being one of the main sources of human salmonellosis. The current study investigated the antivirulence properties of geraniol for inhibiting the in vitro colonization of Salmonella. The minimum inhibitory (MIC) and bactericidal concentrations (MBC) of geraniol against Salmonella typhimurium followed by the sub-MIC of geraniol were determined. Results provided clear evidence that geraniol at 1/8 MIC can be used as an effective, non-toxic antivirulence compound to inhibit virulence factors (motility, adhesion, and invasiveness) affecting the colonization of S. typhimurium on IPEC-J2 cells. Additionally, the findings signified that microfluidics is an emerging technology suitable for the preparation of stable liposomes with a small size (<200 nm) and high encapsulation efficiency (EE) of up to 92.53%, which can act as effective carriers of geraniol into the pig gastrointestinal tract (GIT), targeting Salmonella, preventing colonization, and thus increasing the safety of the food supply chain.
Salmonella is a ubiquitous foodborne
enteric pathogen causing more than 93 million cases of salmonellosis
and 155,000 deaths annually worldwide.[1] According to the latest report of the European Food Safety Authority
(EFSA), in 2021, salmonellosis was the second most frequent cause
of gastrointestinal (GI) infection in humans in the European Union
(EU)[2] as well as in the United States of
America (USA).[3] Human infection with Salmonella has been mainly associated with the direct consumption
of contaminated raw or undercooked poultry and pork products.[4]Salmonella commonly
adheres to the pig intestinal epithelial cells, and infection can
occur at different production stages.[5] For
this reason, Salmonella can be transmitted
through the livestock’s oral–fecal route at the environment,
the farm, the slaughterhouse, and the food processing plant, where
it can survive and cross-contaminate the equipment or the final food
products, causing human infections.[4]S. typhimurium is one of the main well-described
serotypes that are associated with the pig production chain and commonly
multidrug-resistant, causing severe cases in humans.[1,6−8]Excessive use of antibiotics to cure diseases
as well as control
and prevent pathogens in modern animal production plants has led to
the emergence of highly resistant pathogenic bacteria, including Salmonella strains.[8] It
is commonly accepted that there is a dose-dependent relationship between
the use of antibiotics and the development of resistance in bacteria.
In most cases, the animals receive the antibiotics as feed or water
additives. The most resistant zoonotic bacteria constitute a major
public health risk due to their transmission to humans through the
food chain. In the last two decades, an increased prevalence of multidrug-resistant Salmonella strains has been observed to clinically
important antimicrobial agents such as fluoroquinolones and third-generation
cephalosporins used to treat severe Salmonella infections in humans.[14]The increased
antimicrobial resistance associated with the intensive
use of antibiotics has led to searching for new animal production
alternatives. As a result, a broad range of natural essential oils
(EOs) and their major compounds have been used in the last decades
as a substitute to antibiotics in animal feed and to help tackle the
global threat of antibiotic resistance. EOs are secondary metabolites
obtained from plants, spices, herbs, and fruits and consist of a complex
mixture of low-molecular weight compounds.[9−11] EOs can be
used as antivirulence agents, providing an alternative strategy to
inhibit the virulence factors of pathogenic bacteria that facilitate
human disease. The antivirulence approach aims at suppressing the
expression of virulence factors that are crucial for bacterial pathogenicity.[12] This approach does not affect the survival or
growth of the targeted microorganism; thus, it would not change the
overall selective pressures, meaning that is less likely to lead to
the development of resistance.[13]Geraniol (trans-3,7-dimethyl-2,6-oktadien-1-ol)
is a monoterpenic alcohol and naturally occurs as a major compound
in many EOs, such as geranium or rose oils and has many applications
in a variety of products, including food.[14] It is a non-toxic, hydrophobic compound classified in the category
of generally recognized as safe (GRAS) by the US Food and Drug Administration
and the European Food Security Agency.[15] In addition, it is an effective compound that has been highlighted
for its antimicrobial properties against numerous pathogens.[16,17] However, there are only a limited number of studies on the use of
geraniol as an antivirulence agent against bacterial pathogens.[18,19]If geraniol is to be applied as an additive in pig feed or
water,
the initial administrated levels are unlikely to be reached in the
gastrointestinal tract (GIT) since it can be diluted in the gut by
binding to the feed’s protein and lipid constituents.[18] Other reasons limiting the successful application
of hydrophobic compounds as feed/water additives are their low solubility
in aqueous media in parallel with rapid hydrolysis.[22] The use of liposomes has attracted wide attention recently
to encapsulate hydrophobic compounds and improve their solubility,
stability, and bioactivity in the animal’s GIT.[20,21] Liposomes are spherical bilayer vesicles of varying sizes with an
aqueous inner compartment that can be self-assembled naturally or
in vitro with natural or synthetic food-grade lipids accepted as GRAS.[25] Various methods are employed to prepare liposomes,
and most recently, microfluidics has gained popularity. The application
of microfluidics overcomes the problems of conventional methods for
liposome fabrication resulting in more stable and uniform formulations
with high repeatability, showing the potential for large scale production.[23,24] Microfluidics also offers other advantages, such as the fabrication
of liposomes by a simple continuous flow process through the channels
of a microfluidic chip in the sub-nanoliter scale and the use of a
small volume of reagents in significantly less time.[25]The aim of this study was to investigate the antivirulence
properties
of geraniol against S. typhimurium with
focus on the inhibition of motility, adherence, and invasiveness on
IPEC-J2 porcine intestinal epithelial cells. We also aimed to encapsulate
geraniol in liposomal formulations acting as carriers to increase
its stability and solubility in the pig GIT. A comprehensive characterization
of the geraniol loaded liposomes was also performed to determine their
stability, physicochemical characteristics, and in vitro release kinetics.
The potential toxicity of free and encapsulated geraniol on IPEC-J2
cells was also examined.
Materials and Methods
Bacterial
Strain and Growth Conditions
Salmonella enterica serovar Typhimurium (S. typhimurium, ATCC 14028) was used from a frozen
stock stored at −80 °C in Cryoinstant vials with porous
beads (Microbank, Pro-Lab Diagnostics, UK). A single bead was transferred
aseptically in sterile Mueller Hinton broth (MHB; Oxoid, UK) to activate
the culture and incubated overnight at 37 °C. From the overnight
culture, a 100 μL inoculum was transferred in 10 mL MHB and
incubated at 37 °C for 24 h. To prepare the working culture,
the cells were centrifuged at 6500g at 4 °C
for 10 min, washed twice with phosphate-buffered saline (pH 7.4; PBS;
Oxoid, UK), and finally diluted in 10 mL of MHB to an appropriate
bacterial population before use.
Determination of the Minimum
Inhibitory Concentration and Minimum
Bactericidal Concentration of Geraniol
The broth macrodilution
method was used to determine the MIC of geraniol (Merck, UK) at concentrations
of 0.05, 0.10, 0.50, 1.00, 2.00, and 5.00% (v/v) (0.5–50 mg/mL).
Portions of stock geraniol were added in 9.9 mL of MHB before inoculation
to obtain target concentrations (v/v) following the addition of 100
μL of the S. typhimurium inoculum
to reach a final population of approximately 106 CFU/tube.
Test tubes inoculated with S. typhimurium were allowed to incubate at 37 °C for 24 h. The MIC was defined
at the lowest concentration of geraniol, where no turbidity was identified,
meaning the growth of S. typhimurium was inhibited after incubation.MBC was determined by adding
100 μL of suspension from the tubes where no turbidity was identified
on tryptone soy agar (TSA; Oxoid, UK) plates and incubated at 37 °C
for 24 h. The MBC was reported as the minimum concentration of geraniol
at which there was more than 99.9% reduction of the initial inoculum
as determined by plate counts on TSA. Negative controls without geraniol
or bacterial suspension were also included to detect any possible
cross-contamination. All experiments were conducted in triplicate.
Determination of Subinhibitory Concentrations (Sub-MIC) of Geraniol
The broth microdilution method for antibacterial testing was carried
out as recommended by the CLSI protocol[26] with some modifications. To identify the sub-MIC of geraniol against S. typhimurium, 150 μL of MHB was dispensed
in the wells of a sterile 96-well plate. In the first well of each
row, 150 μL of geraniol were added to achieve the MIC value
identified previously, and then two-fold serial dilutions were made.
Next, 150 μL of bacterial suspension was added to each well
to achieve a final population of 1.5 × 106 CFU/mL.
Negative controls without geraniol or S. typhimurium suspension were also included in the last two wells to detect possible
cross-contamination. The 96-well plates were incubated at 37 °C
for 18 h aerobically without shaking using the Omega plate reader
(FLUOstar, Omega, BMG Labtech, UK). The growth kinetics of S. typhimurium were monitored by optical density
measurements at 600 nm (OD600).
Motility Determination
The effect of geraniol on S. typhimurium swarming motility was determined according
to Inamuco et al.[27] A single colony grown
on TSA was stabbed into semisolid medium agar with or without geraniol
at concentrations ranging from 0 to 1/8 MIC. Bacterial motility was
assessed after incubation at 37 °C for 24 h.
Cell Culture
and Adhesion and Invasion to IPEC-J2 Porcine Gut
Epithelial Cells
The intestinal porcine epithelial cells
(IPEC-J2) were grown in Dulbecco’s modified Eagle’s
medium (DMEM)–high-glucose (Sigma-Aldrich, UK) medium supplemented
with 10% fetal bovine serum (FBS; Sigma-Aldrich, UK) at 37 °C
and 5% CO2 in a humidified incubator. For infection and
viability experiments, cells were grown to confluent monolayers in
7 days. Adhesion and invasion assays were performed according to Sima
et al.[28] The adhesion and invasion assays
took place in the presence of geraniol at 1/8, 1/16, and 1/32 MIC
in DMEM. Plate-grown S. typhimurium was harvested, washed, and resuspended in culture medium. Bacteria
were added to the culture plates to give a multiplicity of infection
of 100. Culture plates were centrifuged at 250g for
5 min and incubated for 3 h at 37 °C. All assays were conducted
independently three times.
Preparation of the Liposomal Formulations
The phosphatidylcholine
(PC) liposomes were prepared using a LineUp Push-Pull pressure-controlled
microfluidic system (Fluigent, Paris, FR). The 14:0 PC (DMPC):1,2-dimyristoyl-sn-glycero-3-phosphocholine and 18:0 PC (DSPC): 1,2-dimyristoyl-sn-glycero-3-phosphocholine lipids were purchased from Avanti
Polar Lipids (Alabaster, AL). The microfluidic setup included a reservoir
containing the aqueous solution of sterile PBS (pH 7.4), while the
second one contained the solvent solution [99.8% pure ethanol (Merck,
UK)] with a ratio of 2:1 lipids:cholesterol and geraniol at 1/8 MIC.
A flow rate sensor (Fluigent, Paris, FR) allowed continuous monitoring
of the microfluidic setup’s flow rate. The pressurized reservoirs’
fluids are injected through two separate inlet channels to allow mixing
into a T-shaped microfluidic chip with a zigzag micromixing pattern
(Darwin Microfluidics, Paris, FR). All liposomal formulations were
prepared using the optimal combination of lipids:cholesterol ratio
of 2:1,[29] at a total flow ratio (TFR) of
1 mL/mL and a flow rate ratio (FRR) of 3:1 aqueous:solvent solution
using the Fluigent SDK software (Fluigent, Paris, FR). The above mentioned
liposomal formulation parameters were selected based on previous encapsulation
and stability studies by our group[30] in
order to obtain an appropriate stability profile for PC liposomes.
Investigation of the Physicochemical Characteristics of Liposomes
Determination
of the Particle Size, Polydispersity Index, and
ζ Potential
The stability test for the 14:0 PC (DMPC)
and 18:0 PC (DSPC) with the encapsulated geraniol was performed for
4 weeks. The impact of the storage temperature on the liposomes’
stability was evaluated at 4, 20, and 39 °C. The 4 and 20 °C
temperatures were chosen as they are common refrigeration and room
temperatures. In both temperatures, a wide variety of biological,
pharmacological, and agricultural products that include liposomal
formulations can be stored over a long period and their stability
in the final product is a prerequisite. The 39 °C storage temperature
was chosen as it is the temperature encountered in pig GIT. Samples
were collected the first day of the liposome formulation and every
7 days and were measured for their size, PDI, and ζ-potential.
Ten microliters of the liposomal suspension was collected and added
to 990 μL of PBS (1:100 dilution) and filtered through a 20
μm Millipore filter (Merck, Darmstadt, DE). The final sample
was measured by dynamic light scattering (DLS) on a Zetasizer Nano-ZS
(Malvern Instruments Ltd., UK). For the mean particle’s size
and PDI measurements, a 1 mL disposable cuvette (Merck, UK) was used,
while the Folded Capillary Zeta Cell (Malvern Panalytical, DE) was
used for the determination of ζ potential. A fixed scattering
angle of 137° was used to measure all the physicochemical characteristics
of liposomes.
Fourier Transform Infrared Spectroscopy
Characterization
of the DMPC and DSPC liposomes performed using an attenuated total
reflection (ATR)–FTIR spectrometer (Nicolet 50, Thermo Fisher
Scientific, UK), with built-in ATR. Analysis was performed to confirm
the presence of all compounds within the formulation. All liposomal
formulations were centrifuged at 14800 rpm at 25 °C and the supernatant
was removed before analysis.Scans were performed over a wave
range of 4000–600 cm–1, over 128 scans at
a resolution of 4 cm–1 and an interval of 1 cm–1. Background absorption was subtracted from the analysis.
Atomic Force Microscopy
A TT-2 AFM (AFM Workshop, US)
was used to perform the AFM analysis and assist with the visualization
and further characterization of the liposomal formulations. A volume
of 10 μL from each liposomal formulation was diluted in 1800
μL of PBS. Fifteen microliters of this dilution was then pipetted
onto a freshly cleaved mica surface (1.5 cm × 1.5 cm; G250–2
mica sheets 1″ × 1″ × 0.006″, Agar
Scientific Ltd., Essex, UK). The samples were dried for 30 min and
then imaged under ambient conditions. Ω cm antimony-doped Si
probes (frequency = 167 kHz) were used to image the samples at a scan
rate of 0.6 Hz and 512 × 512-pixel resolution over an area of
5 μm.
Encapsulation Efficiency of Liposomes
The geraniol-loaded
liposome suspension of 1 mL was added in a sterile Eppendorf tube
and centrifuged twice at 11,000g for 20 min. After
centrifugation, the pellets were washed with PBS (pH 7.4) and resuspended
in PBS using the same initial volume before use. All samples collected
were analyzed for geraniol concentration using a UV–Vis spectrophotometer
(GENESYS 150, Thermo Scientific, UK). The geraniol standard solution
was analyzed over the UV wavelength range of 200–400 nm, and
the maximum absorption wavelength of geraniol was 208 nm. The linear
relationship between the concentration of geraniol (x) and the UV absorbance (y) was created according
to the calibration curve of spectrophotometry and was used to calculate
the EE of the liposomes. The equation used to give the final concentration
(%) of the encapsulated compound was
In Vitro Drug Release of
Liposomes under Simulated
Gastrointestinal Conditions
To determine the release rate
of encapsulated geraniol, a three-step protocol simulating the three
different stages of the GIT of pigs was used. First, an aliquot of
1 mL of DMPC and DSPC liposomal geraniol-loaded formulations was added
separately in the cellulose tubing membranes with an average flat
width of 10 mm and 14,000 molecular weight cut-off (MWCO; Sigma, Darmstadt,
DE). The cellulose tubing membrane was boiled for 30 min in distilled
water and rinsed thoroughly before use. The liposomes were transferred
in the dialysis tubing membrane, and both sides were closed using
dialysis tubing closures (Sigma-Aldrich, Darmstadt, DE). The enclosed
liposomes in the dialysis tubing membranes were added separately in
sodium citrate buffer solution with pH values of 2.0, 6.8, and 4.8
for 2, 4, and 18 h at 39 °C, simulating the acid-gastric (AGP),
small intestine (SIP), and large intestine phase (LIP), respectively.
Finally, a 500 μL aliquot was extracted at specific time point
intervals from the immersion medium, which was replaced with a new
buffer solution pre-equilibrated at 39 °C to determine the dilution
parameters. The concentration of free geraniol in the buffer solution
was determined spectrophotometrically at 208 nm. The release rate
(%) of geraniol during digestion was defined by eq :
Effect of Geraniol-Loaded Liposomes on the Viability of IPEC-J2
Porcine Gut Epithelial Cells
The effect on cell viability
was determined by the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium
bromide (MTT) assay (Roche, Sigma-Aldrich, UK) according to Ford et
al.[31] The cells at a population of 2 ×
105 were cultured in a 96-well plate for 18 h to allow
cell attachment at 37 °C in a 5% CO2 atmosphere. The
culture medium was then replaced with 100 μL of fresh medium
containing free geraniol and geraniol-loaded liposomes. Control wells
contained only fresh DMEM medium. After a 3 h incubation period, the
media containing geraniol were removed and the cells were washed once
with 100 μL of the fresh medium and replenished with 100 μL
of fresh medium. Cell survival was evaluated by adding 10 μL
of the MTT reagent (0.5 mg MTT/ml) to each well and incubating for
3 h. Subsequently, the medium was removed, 100 μL of the solubilization
solution was added to dissolve the MTT formazan, and the plate was
left for incubation overnight at 37 °C in a 5% CO2 atmosphere. The quantity of the MTT formazan was measured on an
automatic plate reader (FLUOstar Omega, BMG Labtech, UK) in absorbance
at 570 nm.[28] The viable cells convert MTT
into a purple-colored formazan. Cells viability was expressed as a
percentage of control. All measurements were done in triplicate.
Statistical Analysis
All data were expressed as mean
± standard deviation (SD) and were carried out at least in triplicates.
When required, the data were subjected to a one-way ANOVA followed
by Tukey post hoc test using the IBM SPSS Statistics 22 software (SPSS
Inc., US). For data that showed a normal distribution, Student’s t test was used to determine significance at a 5% level
of significance.
Results and Discussion
MIC and MBC Determination
of Geraniol
In the first
section, the antimicrobial activity of free geraniol was determined
against S. typhimurium. EOs contain a number of compounds, and many of these compounds like
carvacrol[27,32] and thymol[33,34] have been
extensively studied for their antimicrobial and antivirulence effects;
however, there is limited research about the effects of geraniol used
in the current study.Geraniol at a concentration of 0.10% (v/v)
was found to inhibit the growth of S. typhimurium, while a bactericidal effect was observed at the concentration of
0.50% (v/v) (data not shown). Other studies showed that S. typhimurium strains DT104[35] and ATCC 6539[36] exhibited an MIC of 0.025%
(v/v), while the MBCs ranged between 0.037 and 0.050% (v/v), respectively.
In addition, geraniol has been proven to be effective against a number
of different food and clinical pathogenic isolates.[16,17] The antimicrobial effect of EOs and their major compounds, such
as geraniol, is due to their solubility in the phospholipid bilayer
of the cell membrane, leading to increased permeability and loss of
cellular components.[37]
Sub-MIC Determination
of Geraniol
Antivirulence strategy
has emerged as an alternative to conventional antimicrobial drugs,
which act by killing bacteria or inhibiting bacterial growth. Antivirulence
compounds work by inhibiting the virulence factors of the target bacterium.
An increased number of reports underlined the potential of EOs and
their compounds at sub-MICs in inhibiting several virulence factors
of pathogenic bacteria.[13] The current study
provides insights on the antivirulence effect of geraniol at sub-MICs
that can be applied to reduce the pathogenicity of Salmonella by inhibiting specific virulence factors and thus exerting a significantly
less selective pressure for the development of resistance.S. typhimurium was used as the target microorganism
to evaluate the antimicrobial efficacy of geraniol and revealed typical
sigmoidal kinetics and logarithmic growth after 12 h at 37 °C,
as shown by the growth curves at the OD600 range (Figure ). The action of
geraniol at 1/2 MIC was apparent against S. typhimurium, while the bacterial growth was suppressed in the presence of 1/4
MIC. In contrast, growth at 1/8 MIC or lower concentrations appeared
to be identical with the growth in the absence of geraniol (control).
The sub-MICs of 1/8, 1/16, and 1/32 MIC that did not suppress the
bacterial growth were selected and used in further experiments. The
addition of EOs or their major compounds at sub-MIC levels in food
and feed can be used to control and reduce the colonization of foodborne
pathogens without the adverse effects of antibiotic resistance development.
This is consistent with the results reported by Yuan and Yuk,[33] who observed that thymol, carvacrol, and trans-cinnamaldehyde reduced Escherichia
coli O157:H7 motility and biofilm-forming capacity.
Stratakos et al.[32] also investigated the
in vitro effect of sub-inhibitory concentrations of carvacrol against
different Shiga toxin-producing E. coli strains, showing that it can be potentially be applied as an antivirulence
agent in food.
Figure 1
Growth kinetics of S. typhimurium in the presence of sub-MICs of geraniol at 37 °C. The values
represent the mean optical density (OD) of three readings as mean
± SD; n = 3. Sub-MICs used are based on MIC
values presented in the first section.
Growth kinetics of S. typhimurium in the presence of sub-MICs of geraniol at 37 °C. The values
represent the mean optical density (OD) of three readings as mean
± SD; n = 3. Sub-MICs used are based on MIC
values presented in the first section.
Effect of Sub-MICs of Geraniol on the Motility, Adherence, and
Invasiveness of S. typhimurium into
IPEC-J2 Gut Epithelial Cells
Since S. typhimurium is an invasive, facultative intracellular pathogen that requires
adhesion to cause pathogenesis to the host cells, the virulence factors
of motility, adherence, and invasiveness of the pathogen in the presence
of sub-MICs of geraniol were investigated.The 1/32 MIC had
no significant effect on motility (Figure , P < 0.05). Similarly,
no effect on the adhesion and invasion of S. typhimurium into IPEC-J2 gut epithelial cells was observed in the presence of
1/32 MIC (Figure A,B, P < 0.05), compared with the control samples. At 1/16
MIC of geraniol, S. typhimurium showed
significantly reduced motility, whereas the highest motility reduction
was observed when the bacterial cells were exposed to 1/8 MIC (Figure , P < 0.05). The decreased motility observed for S.
typhimurium has also been described for E. coli(38) and S. typhimurium strain DT104 in the presence of carvacrol
at concentrations that do not inhibit bacterial growth. Burt et al.[38] reported that the reduced motility was caused
due to the loss of E. coli flagellum,
while Inamuco et al.[27] presented that S. typhimurium (DT104) cells retained their flagellum
in the presence of carvacrol and the reduced motility might be caused
due to the loss of the flagellum’s functionality or disruption
of bacterial quorum sensing.[39] The results
presented by Yuan and Yuk[33] confirm this
hypothesis where E. coli O157:H7 cells
lost their motility when incubated in soft agar plates supplemented
with sublethal concentrations of thymol and carvacrol due to the downregulation
of the genes responsible for the biosynthesis of flagellar components.
When the bacterial cells are subjected to stress conditions repress
specific activities, such as motility to store energy and carry out
other vital cellular functions.[40] In a
recent study, Zhang et al.[17] reported that
geraniol at various sub-MICs reduced not only the motility of Pseudomonas fluorescens and Pectobacterium
carotovorum but also the production of the exopolysaccharide
inhibiting this way the biofilm formation.
Figure 2
Effect of different concentrations
of geraniol on the motility
of S. typhimurium in soft agar plates.
The bars represent the diameter of the area as mean ± SD; n = 3. Different lowercase letters indicate significant
differences among treatments (P < 0.05).
Figure 3
Adhesion (A) and invasion (B) of IPEC-J2 cells by S. typhimurium. Adhesion and invasion are presented
as percentages relative to the control (set at 100%). The bars represent
the means ± SD; n = 6. Different lowercase letters
indicate significant differences among treatments (P < 0.05).
Effect of different concentrations
of geraniol on the motility
of S. typhimurium in soft agar plates.
The bars represent the diameter of the area as mean ± SD; n = 3. Different lowercase letters indicate significant
differences among treatments (P < 0.05).Adhesion (A) and invasion (B) of IPEC-J2 cells by S. typhimurium. Adhesion and invasion are presented
as percentages relative to the control (set at 100%). The bars represent
the means ± SD; n = 6. Different lowercase letters
indicate significant differences among treatments (P < 0.05).Bacterial motility plays a critical
role in the adhesion and invasion
of the pathogen, which can colonize the GIT.[41] For this reason, it is expected that the reduced motility of S. typhimurium cells found will affect their capacity
to adhere and invade into IPEC-J2 gut epithelial cells. In the current
study, S. typhimurium in the presence
of 1/16 MIC of geraniol did not show a statistically significant reduction
in adhesion ability when compared with the 1/32 MIC and control (Figure A, P > 0.05), while a significantly lower invasion after treatment
was
revealed with 1/16 MIC compared with the control treatment (Figure B, P < 0.05). Although S. typhimurium adheres to the initial pathogenic niches on the cells’ membrane,
infection at the host cell can only be achieved by invasion.[21] Interestingly, the presence of sub-MIC (1/8
MIC) of geraniol resulted in a significant reduction of invasion (50.97%)
and adhesion (31.72%) of S. typhimurium on the IPEC-J2 cells (Figure A,B; P < 0.05). Burt et al.[18] reported that the natural compounds cinnamaldehyde
and carvacrol, at sub-inhibitory concentrations, did not reduce the
adherence of S. typhimurium on IPEC-J2
cells. However, carvacrol at sub-MIC was found to reduce the adherence
of Shiga toxin-producing E. coli strains
on HCT-8 cells.[32] Moreover, other studies
reported the reduced invasion of S. typhimurium on porcine epithelial cells and Campylobacter jejuni on INT-407 intestinal epithelial cells in the presence of 0.5 to
0.8 mM and 0.03 mg/mL of carvacrol, respectively.[27,42] Based on our results, geraniol at sub-MICs could be effectively
applied against Salmonella as an antivirulence agent.
The mechanism by which geraniol and other antivirulence compounds
affect adherence and invasiveness is not yet fully understood. However,
it is known that their sub-inhibitory concentrations can regulate
the genes’ transcription in various pathogens,[43] including Salmonella.[44]
Effect of Storage Temperatures to Physicochemical
Characteristics
of Geraniol-Loaded Liposomes
Liposomal formulations acting
as delivery systems must be stable during storage for commercial applications.
The microfluidic system used in the present study allows for better
control of the particle size as well as increased stability of the
final liposomes during preparation. The physicochemical characteristics
of the formulated liposomes containing the encapsulated sub-MIC (1/8
MIC) of geraniol were evaluated using various techniques. The 1/8
MIC of geraniol was selected as it was the most effective one in inhibiting
motility, adhesion, and invasiveness of S. typhimurium without affecting its growth or survival. The effect of three different
storage temperatures at 4, 20 (room temperature), and 39 °C (pig
GIT temperature) for 28 days was conducted to evaluate the stability
of the liposomes with the encapsulated geraniol.Particle composition
may impact their stability during storage or within the GIT, altering
their local molecular environment.[45] Therefore,
the size, PDI, and ζ potential of the liposomal formulations
were investigated and presented in Tables and 2. The initial
size of the DMPC particles was 192.93 ± 2.04 nm with a PDI value
of 0.225 ± 0.014 and a negative ζ potential charge of −21.23
± 3.96 mV. The mean size of the DMPC particles on day 28 was
149.87 ± 3.43, 155.30 ± 4.48, and 176.50 ± 28.26 nm
at 4, 20, and 39 °C without significant differences among the
different storage temperatures (Table , P > 0.05). The DMPC liposomes
after
28 days of storage at 4 and 20 °C revealed a statistically significant
size decrease compared with day 0 (Table , P < 0.05). The shrinking
observed for the DMPC liposomes might be due to osmosis, where geraniol
is leaving the liposome core to a region of lower concentration (PBS).
A similar phenomenon has been observed by Weaver et al.[30] when the encapsulated bovine serum albumin left
the liposome core causing shrinking of the liposomes during storage.
Regarding the liposomes stored at 4 and 20 °C, the PDI remained
low, showing that the storage temperature did not affect their size
distribution (Table ). A similar PDI of DMPC liposomes was obtained by Ballacchino et
al.[46] In most cases, ζ potential
was in the range of −10 to −20 mV or even higher with
some exceptions, such as for the liposome formulations at 39 °C
after 14 days where a high decrease in size was observed showing lower
stability (Table ).
A large positive or negative value of ζ potential (−25
to +25 mV) indicates good physical stability of nanostructures since
the electrical charge of droplets is strong enough to suggest lower
aggregation.[47] Other factors such as material
properties, the presence of surfactants, solution pH, and ionic strength
may affect the physical stability of the obtained liposomes.[48]
Table 1
Main Physicochemical
Characteristics
of Geraniol-Loaded DMPC (18:0 PC) Liposomes at Various Storage Conditions
for 28 Daysa
day
0
7
14
21
28
size/nm
4 °C
192.93 ± 2.04a,A
169.37 ± 4.21a,B
175.07 ± 3.75a,B
167.43 ± 3.65a,B
149.87 ± 3.43a,C
20 °C
192.93 ± 2.04a,A
161.53 ± 4.54a,B
174.80 ± 1.85a,C
162.50 ± 4.18a,B
155.30 ± 4.48a,B
39 °C
192.93 ± 2.04a,A
171.87 ± 11.22a,A
108.07 ± 3.86b,B
134.00 ± 5.54b,B
176.50 ± 28.26a,A
PDI
4 °C
0.225 ± 0.014a,A
0.123 ± 0.016a,B
0.140 ± 0.018a,B
0.151 ± 0.011a,B
0.081 ± 0.007a,C
20 °C
0.225 ± 0.014a,A
0.102 ± 0.017a,B
0.172 ± 0.020a,C
0.153 ± 0.019a,C
0.065 ± 0.016a,B
39 °C
0.225 ± 0.014a,A
0.252 ± 0.052b,AB
0.340 ± 0.046b,ABC
0.305 ± 0.035b,BC
0.309 ± 0.049b,C
ζ
potential (mV)
4 °C
–21.23 ± 3.96a,A
–5.57 ± 0.70a,B
–14.66
± 3.51a,A
–13.78 ± 8.68a,A
–14.44
± 6.26ab,A
20 °C
–21.23 ± 3.96a,A
–8.20
± 2.00a,B
–7.36 ± 2.93ab,B
–16.75
± 6.37a,A
–8.53 ± 2.40a,B
39 °C
–21.23
± 3.96a,A
–26.20 ± 1.85b,A
–5.06
± 4.66b,B
–21.40 ± 5.57a,A
–22.73
± 6.66b,A
Values followed by different uppercase
letters in each row are significantly different (P < 0.05). Values are presented as means ± SD (n = 3). Values followed by different lowercase letters in the same
column are significantly different (P < 0.05).
All values are presented as means ± SD (n =
3).
Table 2
Main Physicochemical
Characteristics
of Geraniol-Loaded DSPC (14:0 PC) Liposomes at Various Storage Conditions
for 28 Daysa
day
0
7
14
21
28
size (nm)
4 °C
120.27 ± 2.55a,A
128.23 ± 2.22a,AB
132.00 ± 3.08a,B
155.97 ± 5.11 a,C
157.20 ± 4.85a,C
20 °C
120.27 ± 2.55a,AB
114.70 ± 2.42b,A
119.47 ± 1.46b,AB
125.33 ± 2.90b,B
122.07 ± 3.06b,B
39 °C
120.27 ± 2.55a,A
124.83 ± 3.50a,AB
132.13 ± 3.72a,B
129.37 ± 2.08b,B
126.07 ± 2.76b,AB
PDI
4 °C
0.116 ± 0.008a,A
0.093 ± 0.016a,A
0.069 ± 0.027a,A
0.084 ± 0.018a,A
0.086 ± 0.012a,A
20 °C
0.116 ± 0.008a,AB
0.123 ± 0.002b,AB
0.131 ± 0.011b,A
0.116 ± 0.007b,AB
0.107 ± 0.003a,B
39 °C
0.116 ± 0.008a,A
0.128 ± 0.012b,A
0.122 ± 0.018b,A
0.117 ± 0.002b,A
0.099 ± 0.012a,A
ζ
potential (mV)
4 °C
–5.50 ± 1.66a,A
–26.20 ± 9.01a,B
–19.80 ± 4.72a,AB
–21.63 ± 10.05a,B
–20.51
± 5.93a,B
20 °C
–5.50 ± 1.66a,A
–13.93
± 6.38ab,AB
–12.14 ± 2.62a,AB
–18.47
± 6.43a,B
–14.84 ± 5.16a,B
39 °C
–5.50
± 1.66a,A
–7.71 ± 1.13b,A
–13.63
± 6.52a,AB
–17.90 ± 7.64a,B
–20.13
± 4.28a,B
Values followed by different uppercase
letters in each row are significantly different (P < 0.05). Values are presented as means ± SD (n = 3). Values followed by different lowercase letters in the same
column are significantly different (P < 0.05).
All values are presented as means ± SD (n =
3).
Values followed by different uppercase
letters in each row are significantly different (P < 0.05). Values are presented as means ± SD (n = 3). Values followed by different lowercase letters in the same
column are significantly different (P < 0.05).
All values are presented as means ± SD (n =
3).Values followed by different uppercase
letters in each row are significantly different (P < 0.05). Values are presented as means ± SD (n = 3). Values followed by different lowercase letters in the same
column are significantly different (P < 0.05).
All values are presented as means ± SD (n =
3).DSPC liposomes loaded
with geraniol presented an overall lower
particle size of 120.27 ± 2.55 nm on day 0 compared with the
DMPC formulations. Analogous size of DSPC liposomes was obtained by
Guimarães Sá Correia et al.[24] who used the same microfluidic method and FRR of 3:1 (aqueous:solvent
solution). The lower (4 °C) temperature significantly affected
the liposomes, leading to a larger size of 157.20 ± 4.85 nm at
the end of the storage (Table ). Interestingly, the liposomes stored at 20 and 39 °C
showed high size stability without a significant increase even after
28 days (Table , P > 0.05). Temperature is another crucial aspect affecting
the liposomes’ stability during storage.[48] The PDI of the DSPC liposomes confirmed the above results,
while in all cases, it remained close or lower than 0.1, a value indicating
the monodisperse state. Other authors suggest that even a higher PDI
value reaching up to 0.3 indicates homogenous and monodisperse formulations.[49] Additionally, there was a significant increase
in the ζ potential of the DSPC liposomes with the encapsulated
geraniol after 28 days of storage. The liposomes at 4, 20, and 39
°C respectively presented ζ potentials of −20.51
± 5.93, −14.84 ± 5.16, and – 20.13 ±
4.28 without significant differences among the tested temperatures
(Table , P > 0.05). In some cases, fluctuations were observed in the surface
charge of the liposomes. Although we cannot state conclusively the
reason, we hypothesize that the fluctuations may be linked to the
ionic changes in the medium, due to liposome degradation and geraniol
release. Fluctuations at higher storage temperatures might also be
due to the breakage of hydrogen bonds between the phospholipids, causing
the rupture of the liposome membrane.[50] Overall, the above results show the high potential for using DMPC
and DSPC liposomes as efficient delivery vehicles to protect the encapsulated
geraniol from degradation and improve the solubility into the pig
GIT. Also, the liposomes produced in this study showed good stability
for a 4 week storage period at 4, 20, and 39 °C, while similar
results were obtained by Kastner et al.,[51] who showed good liposome stability in terms of size over a period
of up to 8 weeks at 4 and 25 °C.
FTIR Measurements of Liposomes
FTIR spectroscopy was
also used to characterize the DMPC and DSPC geraniol-loaded liposomes,
as it has been proven to be a valuable method to provide insight by
the resulting spectra that act as fingerprints for the tested compounds.[24,30] The characteristic signals on FTIR spectra were marked in Figure .
Figure 4
FTIR spectra of the investigated
antimicrobial compound (a) geraniol
and loaded liposomes with (b) DMPC and (c) DSPC.
FTIR spectra of the investigated
antimicrobial compound (a) geraniol
and loaded liposomes with (b) DMPC and (c) DSPC.The intensity bands of the liposomal formulations DSPC and DMPC
are similar and are displayed by the spectra peaks at approximately
2900 cm–1, representing the C–H single-bond
stretching (Figure b,c).[52] The lack of signals responsible
for the stretching vibrations of −OH groups in geraniol (3317.81
cm–1) on FTIR spectra[14] (Figure a) and the
disappearance of the signals connected with the stretching vibrations
of C=O near 1700 cm–1 confirmed the encapsulation
of geraniol during the preparation of the DMPC and DSPC liposomal
formulations. The characteristic peak at approximately 1050 cm–1, which is in the focus of our investigation, carries
information about the vibrations of P–OR phosphate head groups,
proving the formulation of the liposomes (Figure b,c). In accordance with other studies, the
main difference observed for the tested liposomes was the absorption
intensity of the peaks at 1050 cm–1, which can be
due to the presence of different lipid sizes.[24,30]
AFM Imaging of Liposomes
AFM was used to visualize
all liposomal formulations under dry conditions (Figure ). The DSPC liposomes presented
in Figure B revealed
the smallest size with higher shape uniformity than the DMPC liposomes
in Figure A. Compressed
or flattened spheroidal shapes as observed in our DMPC and DSPC liposomes
are frequently related to AFM technique limitations. It is generally
accepted that many factors can modify the liposomes’ shape,
such as the time of analysis, the type of liposomes, and the forces
applied on them during the scanning procedure.[53] Similar size and shape morphology with our results were
observed for the DMPC-loaded liposomes when AFM imaging was performed.[30] In agreement with Weaver et al.[30] the size observed for both DMPC and DSPC liposomes (Figure A,B) using AFM imaging
was larger compared with the size measured by DLS and ranged up to
300 nm, mainly due to the drying process that the liposomes undertook.
AFM imaging can be used alternatively to the well-established transmission
or scanning electron microscopy to evaluate the liposomes’
physicochemical and technological properties with some limitations
mainly due to the deformation and the increased size observed. In
contrast to our results, where we found a higher size for both DMPC
and DSPC liposomes using AFM imaging compared with the size observed
by DLS, other studies reported that AFM could be an effective tool
to measure the size of the liposomes, offering comparable results
with the DLS analysis.[54,55]
Figure 5
AFM images of (A) DMPC and (B) DSPC geraniol-loaded
liposomes adsorbed
on mica substrate.
AFM images of (A) DMPC and (B) DSPC geraniol-loaded
liposomes adsorbed
on mica substrate.
EE Determination of Geraniol
Following the physicochemical
characterization and stability tests of the liposomes during storage,
the EE of geraniol in DMPC and DSPC lipids was analyzed separately.
Overall, encapsulation is a practical and efficient processing method
to protect the entrapped geraniol, whereas it supports a controlled
and sustained release to inhibit the virulence factors of S. typhimurium, avoiding its colonization in the
pig GIT.Both DMPC- and DSPC-loaded liposomes revealed a high
EE of geraniol. The EE of geraniol in the liposomes formed using the
DSPC lipids was 79.33%, and when DMPC lipids were used, a higher EE
efficiency of 92.53% was observed. In accordance with our results,
Mohammed et al. showed that the lipid composition of the DSPC lipids
due to their longer chain length can result in higher EE.[56] Numerous types of lipids have been used to solubilize
and encapsulate many kinds of hydrophobic extracts and natural compounds,
including atenolol and quinine,[24] curcumin,[46] clove EO and its main component, eugenol,[57,58] and cocoa extract.[59] The EE of the compounds
can vary depending on the method used to prepare the liposomes. Microfluidics
has been proven to offer more stable liposomal formulations with high
EE percentages in agreement with our results.[30]
Geraniol Release from Liposomes
To explore the release
behavior of the encapsulated geraniol, the liposomes were added separately
in a buffer solution with a pH value of 2.0, 6.8, and 4.8 for 2, 4,
and 18 h at 39 °C simulating the pig AGP, SIP, and LIP, respectively.
In Figure , the in
vitro release profiles are presented as the percentage of geraniol
released under each stage of the pig simulated GIT.
Figure 6
Total release rate (%)
of encapsulated geraniol in simulated GIT
for liposomal formulations with 14:0 PC (DMPC) (closed symbols, solid
lines) and 18:0 PC (DSPC) lipids (open symbols, dashed lines). Values
are presented as mean ± SD; n = 3. Asterisks
(*) indicate the significant difference of the release profile of
encapsulated geraniol from DSPC liposomes compared with the DMPC (P < 0.05).
Total release rate (%)
of encapsulated geraniol in simulated GIT
for liposomal formulations with 14:0 PC (DMPC) (closed symbols, solid
lines) and 18:0 PC (DSPC) lipids (open symbols, dashed lines). Values
are presented as mean ± SD; n = 3. Asterisks
(*) indicate the significant difference of the release profile of
encapsulated geraniol from DSPC liposomes compared with the DMPC (P < 0.05).The formulation of DSPC-loaded
liposomes in AGP revealed an initial
burst release of geraniol at 17.19 and 18.05% after 30 min and 1 h,
respectively, while the highest release of 28.06% was observed after
2 h (Figure ). On
the contrary, geraniol released from the DMPC liposomes was significantly
lower and equal with 17.67% after 2 h in the same GIT phase (Figure , P < 0.05). However, geraniol was not released from both liposomal
formulations under the simulated SIP (pH 6.8). The high stability
under these conditions is comparable with the results of Leyva-Jiménez
et al.,[60,61] who reported that the physical stability
of the liposomes remained unchanged at neutral pH 7.0 with high ionic
strength, simulating the gastrointestinal fluids. When indigestible
components such as EOs, flavor oils, and mineral oils are encapsulated
in the lipid’s core, the formulated nanostructures such as
the liposomes used in the current study may remain stable while passing
the small intestine phase.[62] Finally, the
presence of free geraniol after 2 and 4 h in the LIP remained significantly
higher for the DSPC formulations with 8.11 and 10.65% compared to
3.12 and 4.56% released from DMPC liposomes, followed by a sustained
release profile up to 18 h (Figure , P < 0.05). In this study, we
evaluated the release rate of encapsulated geraniol in each stage
of the simulated pig GIT separately. Even though the liposomes performed
well by controlling the immediate release of geraniol in the AGP,
showing no release in the SIP and a sustained release in the LIP,
it would be beneficial for the liposomes to be optimized further in
future studies to increase the release rates in the LIP and achieve
a more targeted delivery. Although in vitro digestion models can provide
useful information, they do have limitations.[21] There are additional factors that can influence the release of geraniol
from liposomes in the animal gut. The presence of enzymes and bile
salts produced during digestion can influence liposome stability and,
thus, the in vivo drug release.[63,64] Also, enzymes present
during digestion (e.g., from the pancreas and gut microbiota) could
also influence drug release from liposomes.[65] Moreover, the composition of the feed given to the animal also plays
a role, as liposomes may be exposed to various types of components
that could interact with the lipid membrane and influence geraniol
release.[66]Therefore, in vivo release
will be explored in a future study to
better assess the effectiveness of geraniol.[24] Overall, our data suggest that the DSPC liposomes revealed a faster
and higher release of the encapsulated geraniol when compared with
the DMPC formulations. As the drug release is one of the main endogenous
factors influencing bioavailability, geraniol encapsulation in DSPC
lipids could potentially lead to better bioavailability and a higher
likelihood of exerting its antivirulence effects against S. typhimurium.
Effect of Free and Encapsulated
Geraniol on the Viability of
IPEC-J2 Porcine Gut Epithelial Cells
Despite the desirable
antivirulence effect of geraniol observed above, when considering
the viability of the porcine cells, the potential toxicity of free
and encapsulated geraniol must be addressed. Hence, the possible toxicity
of free and encapsulated geraniol on the viability of IPEC-J2 porcine
epithelial cells is presented in Figure .
Figure 7
Effect of free and encapsulated geraniol in
DMPC and DSPC liposomes
on the viability of IPEC-J2 porcine epithelial cell line. H2O2 was used as the control. The bars represent the means
± SD; n = 3. Different lowercase letters indicate
significant differences among treatments (P <
0.05).
Effect of free and encapsulated geraniol in
DMPC and DSPC liposomes
on the viability of IPEC-J2 porcine epithelial cell line. H2O2 was used as the control. The bars represent the means
± SD; n = 3. Different lowercase letters indicate
significant differences among treatments (P <
0.05).The IPEC-J2 cell line has been
widely used for mimicking the porcine
and human gut, and in that view, this cell line is a helpful first
step in screening potential diet additives prior to in vivo animal
feeding.[18] When IPEC-J2 cells were exposed
to hydrogen peroxide (H2O2), a significantly
lower cell viability of 74.42% was observed in comparison with the
free or encapsulated geraniol (Figure , P < 0.05). Our results showed
that a sub-MIC (1/8 MIC) of free or encapsulated geraniol in both
DMPC and DSPC lipids had no significant adverse effect on IPEC-J2
viability compared with the control (Figure , P > 0.05). This is
the
first study investigating the potential cytotoxic effect of free and
encapsulated geraniol on the IPEC-J2 porcine gut epithelial cells.
Other studies showed that natural compounds such as carvacrol can
have cytotoxic effects on gut epithelial cells[27] and other cell lines,[67,68] suggesting
a dose-dependent cytotoxic effect. At present, there is an increased
interest in the successful delivery of natural compounds in the GIT
to increase their bioavailability and determine their toxicity on
epithelial cells at the target site. Silva et al.[69] reported that single (oil-in-water)- and multilayer nanoemulsions
improved the bioavailability of curcumin in the GIT, but both showed
a toxicity for Caco-2 cells due to the use of sodium dodecyl sulfate
as a surfactant. Our results showed that encapsulated geraniol could
potentially be used as an antivirulence compound targeting specific
virulence factors to reduce the colonization of S.
typhimurium without inhibiting the growth of the bacterial
cells or causing cytotoxic effects to pig gut epithelial cells. Thus,
the control strategy developed could potentially help increase food
safety by reducing the presence of Salmonella in
pork production. However, further in vivo studies to determine the
bioavailability and biological fate of geraniol and release during
digestion are necessary to prove the usefulness of this strategy conclusively.
Authors: S Karkabounas; O K Kostoula; T Daskalou; P Veltsistas; M Karamouzis; I Zelovitis; A Metsios; P Lekkas; A M Evangelou; N Kotsis; I Skoufos Journal: Exp Oncol Date: 2006-06
Authors: Nathalia Dias Gonçalves; Fabíola de Lima Pena; Adilson Sartoratto; Camila Derlamelina; Marta Cristina Teixeira Duarte; Adriane Elisabete Costa Antunes; Ana Silvia Prata Journal: Food Res Int Date: 2017-03-04 Impact factor: 6.475
Authors: Sara A Burt; Ruurd van der Zee; Ad P Koets; Anko M de Graaff; Frans van Knapen; Wim Gaastra; Henk P Haagsman; Edwin J A Veldhuizen Journal: Appl Environ Microbiol Date: 2007-05-25 Impact factor: 4.792
Authors: Lieke B van Alphen; Sara A Burt; Andreas K J Veenendaal; Nancy M C Bleumink-Pluym; Jos P M van Putten Journal: PLoS One Date: 2012-09-25 Impact factor: 3.240
Authors: Sara A Burt; Simone J M Adolfse; Dina S A Ahad; Monique H G Tersteeg-Zijderveld; Betty G M Jongerius-Gortemaker; Jan A Post; Holger Brüggemann; Regiane R Santos Journal: Phytother Res Date: 2016-08-25 Impact factor: 5.878